Breakout Ventures launches $114M Fund III
Breakout Ventures, an early-stage investor focused on frontier science, has closed its third fund at $114 million, targeting startups at the intersection of AI, biology and chemistry. The raise underscores surging investor appetite for platforms that apply machine learning and automation to drug discovery, materials science and diagnostics.
The new vehicle follows a major liquidity event from portfolio company Surf Bio, which was acquired by Halozyme in a deal valued at around $400 million. That exit has strengthened the firm’s track record and reinforced its thesis that combining deep science with scalable AI-powered platforms can generate both outsized returns and real-world impact.
Backing AI-first biology and chemistry startups
With Fund III, Breakout Ventures plans to lead and co-lead seed and Series A rounds in companies building core computational biology, lab automation and data infrastructure technologies. Existing portfolio companies such as Cytovale and Twelve exemplify this strategy: both leverage advanced data analytics and AI models to accelerate decision-making in healthcare and climate-related chemistry, respectively.
The firm has also made early bets like Reach Industries, which develops tools to automate and scale complex laboratory workflows. These startups aim to compress experimental timelines, reduce failure rates and make high-value R&D more capital efficient.
Positioning in a competitive deep tech landscape
Fund III positions Breakout Ventures as a specialist investor in a crowded deep tech and AI funding environment. While generalist funds are increasingly active in the space, the firm’s focus on applied science, paired with a history of hands-on support for technical founders, is designed to differentiate its approach.
By concentrating capital on AI-native platforms in biology and chemistry, Breakout Ventures is betting that the next generation of category-defining companies will emerge where powerful AI algorithms meet tangible, high-impact problems in medicine, materials and climate.